XML 48 R34.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
SUMMARY OF STOCK-BASED COMPENSATION EXPENSE RECOGNIZED FOR STOCK OPTION AWARDS

The Company has recorded stock-based compensation expense related to the issuance of restricted stock awards in the following line items in the accompanying condensed consolidated statements of operations:

 

   2024   2023 
         
Research and development  $99,174   $37,131 
Selling, general and administrative   890,507    711,692 
Total stock-based compensation expense  $989,681   $748,823 
SUMMARY OF OPTION ACTIVITY

The following table summarizes stock option activity under the 2014 and 2024 Plans:

 

  

Number of

options

  

Weighted-

average

exercise price

  

Weighted-

average

remaining

contractual

term (in years)

  

Aggregate

intrinsic value

 
Outstanding at December 31, 2023   683,695   $3.99    2.9   $158,332 
Granted                
Exercised   (208,031)   1.16         
Forfeited   (171,539)   2.16         
Outstanding at December 31, 2024   304,125   $6.95    4.20   $ 
                     
Vested and exercisable at December 31, 2024   304,125   $6.95    4.20   $ 
SUMMARY OF RESTRICTED STOCK AWARD

The following table summarizes restricted stock award activity under the 2014 and 2024 Plan:

 

               As of December 31, 2024 
   Number of
restricted
stock awards
(RSA)
   Weighted-
average
grant price
   FMV on
grant date
   Vested
number
of RSA
   Unvested
number
of RSA
 
Balance at December 31, 2023   540,969   $2.24   $1,209,400    462,298    78,671 
Granted   865,423    1.81    1,570,834    517,941    347,482 
Forfeited   (77,096)   1.80    (139,173)       (77,096)
Balance at December 31, 2024   1,329,296   $2.24   $2,641,061    980,239    349,057